The American Academy of Pediatrics (AAP) has announced new cholesterol screening and treatment recommendations Media release 13 February 2013 Pages: 2 - 2
Rituximab reigns over abatacept as alternative to anti-TNF therapy Clinical study 13 February 2013 Pages: 3 - 3
Hospital charges for infectious disease in elderly increase Clinical study 13 February 2013 Pages: 5 - 5
The number of patients who received antibiotic treatment associated with a positive culture for MRSA increased over 1 year, Media release 13 February 2013 Pages: 5 - 5
Macrogol 4000 cost effective, but how beneficial is it really? Clinical study 13 February 2013 Pages: 7 - 7
The prophylactic use of botulinum toxin A in patients with chronic migraine may reduce the total cost of acute migraine medications, Clinical study 13 February 2013 Pages: 9 - 9
Doses of Β-blockers being prescribed to elderly veterans with heart failure are much lower than target doses, Clinical study 13 February 2013 Pages: 9 - 9
The US FDA is responsible for the down-turn in new drug approvals, News item 13 February 2013 Pages: 10 - 10
The market for renal cell carcinoma drugs will more than double over the next decade, Media release 13 February 2013 Pages: 10 - 10
Novartis has announced that its zoledronic acid [Aclasta] will not be reimbursed in Canada, Media release 13 February 2013 Pages: 10 - 10
The market for drugs aimed at treating hepatitis C will increase almost five-fold in the next 10 years, Media release 13 February 2013 Pages: 11 - 11
Quebec has become the first Canadian province to reimburse the rivastigmine [Exelon] transdermal patch, Media release 13 February 2013 Pages: 11 - 11